Area of research
Endocrinology, Diabetes and Metabolism · Economics and Econometrics
Research interest
Research interests include Diabetes Treatment and Management, Diabetes Management and Research, Health Systems, Economic Evaluations, Quality of Life, and Diabetes, Cardiovascular Risks, and Lipoproteins.
GLP-1RA Use and Thyroid Cancer Risk
Sex differences in the risk of Mycobacterium tuberculosis infection: a systematic review and meta-analysis of population-based immunoreactivity surveys
Incidence and Risk Factors of Diagnosed Young-Adult-Onset Type 2 Diabetes in the U.S.: The National Health Interview Survey 2016–2022
Artificial Intelligence in Diabetes Care: Applications, Challenges, and Opportunities Ahead
Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity
GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes
Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review
Newer <scp>glucose‐lowering</scp> drugs and risk of dementia: A systematic review and <scp>meta‐analysis</scp> of observational studies
5‐Year simulation of diabetes‐related complications in people treated with tirzepatide or semaglutide versus insulin glargine